Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

NCT06369610 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Oligometastatic Prostate Carcinoma
Prostate Adenocarcinoma

Interventions

DRUG: Abiraterone Acetate
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Gonadotropin-releasing Hormone Analog
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy

Sponsor

Mayo Clinic